Analytics

Lunit and Coreline Soft have been tapped to join large-scale cancer screening programs.

While AI technology shows promise for automating administrative tasks, Julie Frey, vice president of provider product at Wolters Kluwer, recommends caution in deploying AI, particularly generative AI, for clinical use cases.

The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.

While decentralizing healthcare data using blockchain can potentially bolster organizations' cybersecurity, Matt Murren, CEO of True North ITG, cautions that quantum computing may one day crack blockchain's ciphers.

Also, TruScreen has secured a new distribution deal to reenter India.

Hal Wolf, president and CEO of HIMSS, provides highlights of the upcoming HIMSS25 Europe conference in Paris, including innovations within the European Union and discussions on how the healthcare market is evolving within the region.

It joins Lunit and Us2.ai in the vendor-neutral, cloud-based marketplace of medical AI solutions.

Also, Lytus adds an AI-driven blood logistics platform to its health technology portfolio.

Georgia's Piedmont Healthcare leverages claims data, EMR data and predictive analytics to find patients who may need support to stay on their medication regimen, explains population health pharmacy program manager Melissa Robinson.

The funding comes on the heels of Carta Healthcare’s acquisition of Realyze Intelligence last year.